Safety evaluation of pharmacological interventions: a review of recent published meta-analysis

Alves C, Macedo AF, Craveiro N, Batel Marques F

Pharmacoepidemiol Drug Saf 2011;20:S351

2011

Increased severity of adverse drug reactions reported from hospitals.

Batel Marques FJ, Alves C, Craveiro N, Fontes-Ribeiro C, Macedo AF

Pharmacoepidemiol Drug Safe 2011;20:S330

2011

Hypersensitivity syndrome due to drug exposure – ten years case review.

Craveiro N, Alves C, Fontes Ribeiro C,Batel Marques FJ

Pharmacoepidemiol Drug Saf 2011;20:S332-S333

2011

Omissão de fármacos modificadores do risco cardiovascular em idosos admitidos numa Unidade de Acidentes Vasculares Cerebrais.

Borges EP, Macedo AF

Rev Port Clin Geral 2011;27:140-150

2011

Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.

Alves C, Macedo AF, Batel Marques F

Pharmacotherapy 2011;31(10):357e

2011

Fecundação in vitro em Portugal: um estudo de custo-efectividade.

Silva V, Pita Barros P, Lourenço O, Batel-Marques F.

Rev Port Farmacoter 2011;3:139-153

2011

Data sources on drug safety evaluation: a review of recent published meta-analysis.

Alves C, Batel Marques F, Macedo AF

Pharmacoepidemiol Drug Saf 2012;21(1):21-33

2011

Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.

Alves C, Batel-Marques F, Macedo AF.

J Cardiovasc Pharmacol Therap 2011 1 Dec. doi: 10.1177/1074248411427402

2011